On November 07, 2024, Factor-H will host a fundraising event in Los Angeles to support our ongoing programs in Latin America. Factor-H is proud to
What a week it has been! Factor-H is again recognized for its public service to underserved Latin American HD families at the International Congress of
Factor-H ‘La Luz’ Caregivers program wins the 2024 Amgen/MIT Solve award at the Concordia Summit We are extremely honored and humbled by this award, which
We are honored to be 1 of 5 finalist nonprofit organizations being nominated for this prestigious award, selected out of 90 applicant organizations. The award
Ayer, Uniqure informó sobre los resultados de 24 meses de su ensayo clínico de fase 1/2 con AMT-130, un ensayo de terapia génica viral para reducir el HTT en el
De una mutación genética a una enfermedad letal La EH es causada por una única mutación en una región del gen HTT, ubicada en la
Factor-H is a registered 501-(c)3 non-profit foundation in the United States (EIN 82-5395108)
English 
Spanish 
Portuguese